Yes, both hyperfractionation and hypofractionation can potentially alter tumor radioresistance patterns compared to conventional fractionation (CF). Here's a breakdown of how they might do so:

**1. Hyperfractionation:**

*   **Definition:** Delivering smaller doses per fraction but increasing the total number of fractions over a longer period (e.g., 1.15 Gy twice daily instead of 2 Gy once daily).
*   **Mechanism for Altering Resistance:**
    *   **Reduced Repair Time:** The shorter interval between fractions leaves less time for sublethal damage repair within the tumor cells. This is particularly relevant for rapidly proliferating tumors where DNA repair mechanisms are highly active. By reducing the opportunity for repair, hyperfractionation aims to overcome acquired resistance due to efficient repair pathways.
    *   **Increased Oxygen Effect:** Some studies suggest that hyperfractionation may enhance the therapeutic ratio by exploiting differences in oxygen levels between normal tissues and hypoxic tumor regions. Hypoxic cells are more resistant to radiation, but their sensitivity increases when reoxygenated. Frequent dosing might promote better reoxygenation in certain parts of the tumor.
    *   **Targeting Different Cell Populations:** It might preferentially kill slowly cycling cells while sparing actively dividing stem cells, which could be beneficial in some contexts. Conversely, it might also target radiosensitive populations more effectively before they become resistant.
*   **Clinical Relevance:** Often used in head and neck cancers, cervical cancer, and sometimes breast cancer, aiming to improve local control and reduce toxicity by targeting specific cell cycle phases or overcoming repair.

**2. Hypofractionation:**

*   **Definition:** Delivering larger doses per fraction but decreasing the total number of fractions over a shorter period (e.g., 3 Gy once daily instead of 1.8 Gy five times weekly). Includes techniques like Stereotactic Body Radiation Therapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR), proton therapy with RBE considerations, etc.
*   **Mechanism for Altering Resistance:**
    *   **Overcoming Repopulation:** For slow-growing tumors, CF allows significant repopulation during treatment. Hypofractionation delivers higher doses quickly, potentially killing more cells before substantial regrowth occurs, thus overcoming resistance related to proliferation.
    *   **Exploiting Differential Response:** Larger dose fractions induce greater initial damage. While this causes more acute toxicity, it might disproportionately affect sensitive tumor cells compared to relatively radioresistant normal tissues, especially